WESTERN RESEARCH ALLIANCE
Fifth T-BED Luncheon
Dr. James Swartz
From Campus Concept to Commercialization
December 16, 2005
 The Western Research Alliance, the Alumni Association
of the South Dakota School of Mines and Technology and Black Hills State
University welcomed
Dr. James Swartz to present at the fifth luncheon of the T-BED (Technology
Based Economic Development) series of invited speakers on December 16th.
The title of his presentation was "From Campus Concept to Commercialization".
Dr. Swartz has been involved with the Avian Flu vaccine research.
On Saturday, December 17, Dr. James Swartz was honored at
the SDSM&T
Fall Commencement as one of five Distinguished Alumni Award recipients.
A native of Baltic, SD, Dr. Swartz received a B.Sc. degree in Chemical
Engineering from SDSM&T in 1971, a M.Sc. degree in Chemical Engineering
from MIT in 1975, and a D.Sc. degree in Biochemical Engineering from MIT
hi 1978. After graduation from MIT, he spent some time as a visiting scientist
in the USSR before joining Eli Lilly & Co. as a Senior Scientist in
antibiotic process development. In 1981, he joined Genentech Inc. where
for some 18 years he held various scientific and management positions in
fermentation and cell culture research. In 1998, Dr. Swartz moved to Stanford
University as a Professor of Chemical Engineering and directed his research
focus to the area of cell-free protein synthesis with applications to pharmaceutical
production, patient-specific medicine, hydrogen production, and water purification.
Dr. Swartz and his colleagues at Stanford University have founded Fundamental
Applied Biology Inc. in San Francisco to commercialize the technique of
exploiting the protein-making characteristics of living cells to produce
protein-based medicinal drugs.
|
